Cargando…

Renal ROCK Activation and Its Pharmacological Inhibition in Patients With Diabetes

Rho-associated coiled-coil-containing protein kinase (ROCK) is a serine/threonine kinase with essential roles in cytoskeletal functions. Substantial evidence implicates ROCK as a critical regulator in the inception and progression of diabetic nephropathy through a mechanism involving mesangial fibro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Matoba, Keiichiro, Sekiguchi, Kensuke, Nagai, Yosuke, Takeda, Yusuke, Takahashi, Hiroshi, Yokota, Tamotsu, Utsunomiya, Kazunori, Nishimura, Rimei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454778/ https://www.ncbi.nlm.nih.gov/pubmed/34557101 http://dx.doi.org/10.3389/fphar.2021.738121

Ejemplares similares

The Physiology, Pathology, and Therapeutic Interventions for ROCK Isoforms in Diabetic Kidney Disease
por: Matoba, Keiichiro, et al.
Publicado: (2020)

ROCK Inhibition May Stop Diabetic Kidney Disease
por: Matoba, Keiichiro, et al.
Publicado: (2020)

Endothelial Dysfunction in Diabetes
por: Takeda, Yusuke, et al.
Publicado: (2020)

ROCK2-induced metabolic rewiring in diabetic podocytopathy
por: Matoba, Keiichiro, et al.
Publicado: (2022)

Targeting Redox Imbalance as an Approach for Diabetic Kidney Disease
por: Matoba, Keiichiro, et al.
Publicado: (2020)

ROCK2 Regulates Monocyte Migration and Cell to Cell Adhesion in Vascular Endothelial Cells
por: Takeda, Yusuke, et al.
Publicado: (2019)

Unraveling the Role of Inflammation in the Pathogenesis of Diabetic Kidney Disease
por: Matoba, Keiichiro, et al.
Publicado: (2019)

SGLT2 Inhibitors as a Therapeutic Option for Diabetic Nephropathy
por: Kawanami, Daiji, et al.
Publicado: (2017)

Rho-Kinase Blockade Attenuates Podocyte Apoptosis by Inhibiting the Notch Signaling Pathway in Diabetic Nephropathy
por: Matoba, Keiichiro, et al.
Publicado: (2017)

Which is better, high‐dose metformin monotherapy or low‐dose metformin/linagliptin combination therapy, in improving glycemic variability in type 2 diabetes patients with insufficient glycemic control despite low‐dose metformin monotherapy? A randomized, cross‐over, continuous glucose monitoring‐based pilot study
por: Takahashi, Hiroshi, et al.
Publicado: (2018)

Prospective randomized study for optimal insulin therapy in type 2 diabetic patients with secondary failure
por: Miyashita, Yumi, et al.
Publicado: (2008)

SUN-522 A Case of Diabetic Ketoacidosis Associated with Thyroid Storm
por: Watanabe, Yui, et al.
Publicado: (2020)

Prediction of nocturnal hypoglycemia unawareness by fasting glucose levels or post-breakfast glucose fluctuations in patients with type 1 diabetes receiving insulin degludec: A pilot study
por: Takahashi, Hiroshi, et al.
Publicado: (2017)

Incretin-Based Therapies for Diabetic Complications: Basic Mechanisms and Clinical Evidence
por: Kawanami, Daiji, et al.
Publicado: (2016)

Prevalence of albuminuria and renal dysfunction, and related clinical factors in Japanese patients with diabetes: The Japan Diabetes Complication and its Prevention prospective study 5
por: Shikata, Kenichi, et al.
Publicado: (2019)

Genetic and Pharmacological Inhibition of p38α Improves Locomotor Recovery after Spinal Cord Injury
por: Umezawa, Hiroki, et al.
Publicado: (2017)

Effect of Hemodialysis on Plasma Glucose Profile and Plasma Level of Liraglutide in Patients with Type 2 Diabetes Mellitus and End-Stage Renal Disease: A Pilot Study
por: Osonoi, Takeshi, et al.
Publicado: (2014)

Pharmacological and Genetic Inhibition of HDAC4 Alleviates Renal Injury and Fibrosis in Mice
por: Shen, Fengchen, et al.
Publicado: (2022)

24-Hour Glycemic Variations in Drug-Naïve Patients with Type 2 Diabetes: A Continuous Glucose Monitoring (CGM)-Based Study
por: Ando, Kiyotaka, et al.
Publicado: (2013)

Can Fasting Glucose Levels or Post-Breakfast Glucose Fluctuations Predict the Occurrence of Nocturnal Asymptomatic Hypoglycemia in Type 1 Diabetic Patients Receiving Basal-Bolus Insulin Therapy with Long-Acting Insulin?
por: Mitsuishi, Sumie, et al.
Publicado: (2015)

Unexpected Acute Hyperglycemia Following Pre-Surgical Discontinuation of SGLT2 Inhibitors in a Type 1 Diabetic Patient
por: Tsujimoto, Yuki, et al.
Publicado: (2023)

Axon growth inhibition by RhoA/ROCK in the central nervous system
por: Fujita, Yuki, et al.
Publicado: (2014)

Interactions between Serum Vitamin D Levels and Vitamin D Receptor Gene FokI Polymorphisms for Renal Function in Patients with Type 2 Diabetes
por: Yokoyama, Keitaro, et al.
Publicado: (2012)

Editorial: Insights in renal pharmacology: 2021
por: Perico, Norberto, et al.
Publicado: (2022)

Editorial: Women in renal pharmacology: 2021
por: Benigni, Ariela, et al.
Publicado: (2022)

Editorial: Be positive about the negative in pharmacology: clinical studies in renal pharmacology 2022
por: Prasad, Narayan, et al.
Publicado: (2023)

Comparison of vildagliptin twice daily vs. sitagliptin once daily using continuous glucose monitoring (CGM): Crossover pilot study (J-VICTORIA study)
por: Sakamoto, Masaya, et al.
Publicado: (2012)

Age at Transition from Pediatric to Adult Care Has No Relationship with Mortality for Childhood-Onset Type 1 Diabetes in Japan: Diabetes Epidemiology Research International (DERI) Mortality Study
por: Onda, Yoshiko, et al.
Publicado: (2016)

Biphasic insulin aspart‐30 reduces glycemic variability to a greater degree than insulin detemir: A randomized controlled trial of once‐daily insulin regimens using continuous glucose monitoring
por: Tsujino, Daisuke, et al.
Publicado: (2017)

Editorial: Model organisms in renal pharmacology: 2022
por: Mahmoud, Ayman M., et al.
Publicado: (2023)

The Function of Rho-Associated Kinases ROCK1 and ROCK2 in the Pathogenesis of Cardiovascular Disease
por: Hartmann, Svenja, et al.
Publicado: (2015)

Is it possible to predict the onset of nocturnal asymptomatic hypoglycemia in patients with type 1 diabetes receiving insulin degludec? Potential role of previous day and next morning glucose values
por: Takahashi, Hiroshi, et al.
Publicado: (2020)

ROCK inhibition as a therapy for spinal muscular atrophy: understanding the repercussions on multiple cellular targets
por: Coque, Emmanuelle, et al.
Publicado: (2014)

Transcriptomic analysis and 3D bioengineering of astrocytes indicate ROCK inhibition produces cytotrophic astrogliosis
por: O'Shea, Ross D., et al.
Publicado: (2015)

Pharmacological Inhibition of STING/TBK1 Signaling Attenuates Myeloid Fibroblast Activation and Macrophage to Myofibroblast Transition in Renal Fibrosis
por: Zeng, Haimei, et al.
Publicado: (2022)

OAT10/SLC22A13 Acts as a Renal Urate Re-Absorber: Clinico-Genetic and Functional Analyses With Pharmacological Impacts
por: Toyoda, Yu, et al.
Publicado: (2022)

The relationship between HbA1c values and the occurrence of hypoglycemia as assessed by continuous glucose monitoring in patients with type 1 diabetes
por: Tsujino, Daisuke, et al.
Publicado: (2016)

Non-Alcoholic Fatty Liver Disease Markers Associated with Fasting Serum Insulin and Urinary Albumin Excretion Independent of Fasting Plasma Glucose
por: Katoh, Shuichi, et al.
Publicado: (2020)

Systems pharmacology of adiposity reveals inhibition of EP300 as a common therapeutic mechanism of caloric restriction and resveratrol for obesity
por: Nishimura, Yuhei, et al.
Publicado: (2015)

Pharmacological Inhibition of HMGB1 Prevents Muscle Wasting
por: Li, Lu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_m94pm9rnp8rno1sd4p7ksbjkmm